PharmaShots | Incisive News in 3 Shots

Subscribe Now

Cantargia

Cantargia Plans to Evaluate Nadunolimab Against Metastatic Pancreatic Cancer

Cantargia Plans to Evaluate Nadunolimab Against Metastatic Pancreatic Cancer

January 3, 2022

Cantargia Reports Updated Interim Results of Nadunolimab in P-I/IIa (CANFOUR) Trial for the Treatment of Pancreatic Cancer

Cantargia Reports Updated Interim Results of Nadunolimab in P-I/IIa (CANFOUR) Trial for the Treatment of Pancreatic Cancer

December 30, 2021

PharmaShots Weekly Snapshot (August 19 - 23, 2019)

PharmaShots Weekly Snapshot (August 19 - 23, 2019)

August 26, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us